Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites

about

Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites

Item

http://www.wikidata.org/entity/Q57124811

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Deficiency of Follistatin-Like ...... Cells at Lung Metastatic Sites

@en

Deficiency of Follistatin-Like ...... Cells at Lung Metastatic Sites

@nl

type

Item

label

Deficiency of Follistatin-Like ...... Cells at Lung Metastatic Sites

@en

Deficiency of Follistatin-Like ...... Cells at Lung Metastatic Sites

@nl

prefLabel

Deficiency of Follistatin-Like ...... Cells at Lung Metastatic Sites

@en

Deficiency of Follistatin-Like ...... Cells at Lung Metastatic Sites

@nl

P1476

Deficiency of Follistatin-Like ...... Cells at Lung Metastatic Sites

@en

P2093

Bing Chen

http://www.w3.org/2001/XMLSchema#string

Jie Ma

http://www.w3.org/2001/XMLSchema#string

Ling Qin

http://www.w3.org/2001/XMLSchema#string

Lulu Wang

http://www.w3.org/2001/XMLSchema#string

Tao Lu

http://www.w3.org/2001/XMLSchema#string

Xiangzhi Meng

http://www.w3.org/2001/XMLSchema#string

Xiaozhou Xu

http://www.w3.org/2001/XMLSchema#string

Yan Gao

http://www.w3.org/2001/XMLSchema#string

Ying Yang

http://www.w3.org/2001/XMLSchema#string

Ying Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer

Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development

Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China.

Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR.

Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis.

Molecular basis of triple negative breast cancer and implications for therapy.

Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide.

A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expression.

P304

267-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4048/JBC.2018.21.E43

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30275855

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6158165

http://www.w3.org/2001/XMLSchema#string